ENTITY
Celltrion Healthcare

Celltrion Healthcare (091990 KS)

216
Analysis
Health Care • South Korea
Celltrion Healthcare Co.,Ltd develops and manufactures pharmaceutical biologics and chemically synthesized drugs. The Company specializes in the development of drugs for breast cancer, arthritis, leukemia, psoriasis, human rabies prevention, and influenza. Celltrion Healthcare markets its products to customers internationally.
more
bullish•Celltrion Inc
•17 Dec 2022 18:33

Celltrion Siblings Announced Dividends: Trading Based on Past Patterns

The three Celltrion companies all announced yearend dividends last Friday after the market closed. This post investigates past patterns for how we...

Logo
708 Views
Share
bullish•Celltrion Inc
•17 Dec 2022 03:19

Celltrion Group Companies - Sharp Increase in Dividends

Celltrion Inc, Celltrion Healthcare, and Celltrion Pharm all announced much higher dividend payments for this year as compared to last year.

Logo
724 Views
Share
bullish•Ecopro BM
•21 Aug 2022 15:37

Overheated Short Selling Designation in Korea: Precise Definitions for the Confusing Terms

This post aims to explain Korea's overheated short-selling designation rules and provide precise definitions for the confusing terms.

Logo
558 Views
Share
bearish•Celltrion Inc
•04 Jun 2022 15:29

FnGuide Top 10 Rebalancing: How We Trade Shinhan IN/Celltrion OUT

This post looks at the FnGuide Top 10 Index (TIGER ETF) rebalancing results as we are past the screening period and suggests a trading approach on...

Logo
702 Views
Share
bullish•JD.com (ADR)
•27 Mar 2022 07:49

ECM Weekly (27th Mar 2022) - JD, Tencent, Prosus, Ferretti, Recbio, Nomura, Navi, Samsung, Celltrion

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Logo
571 Views
Share
x